Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life

Maiko InoueDepartment of Ophthalmology, Yokohama City University Medical Center, Yokohama, JapanCorrespondence[email protected]

Akira ArakawaDepartment of Ophthalmology, Yokohama City University Medical Center, Yokohama, Japan

Shin YamaneDepartment of Ophthalmology, Yokohama City University Medical Center, Yokohama, Japan

Kazuaki KadonosonoDepartment of Ophthalmology, Yokohama City University Medical Center, Yokohama, Japan

Pages 1711-1716 | Published online: 04 Sep 2014

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

BresslerNMBresslerSBFineSLAge-related macular degenerationSurv Ophthalmol1988323754132457955
PubMed Web of Science ®Google Scholar
BresslerNMBresslerSBCongdonNGPotential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11Arch Ophthalmol20031211621162414609922
PubMed Web of Science ®Google Scholar
BresslerNMAge-related macular degeneration is the leading cause of blindnessJAMA20042911900190115108691
PubMed Web of Science ®Google Scholar
FerrisFL3rdFineSLHymanLAge-related macular degeneration and blindness due to neovascular maculopathyArch Ophthalmol1984102164016426208888
PubMed Web of Science ®Google Scholar
MangioneCMLeePPPittsJGutierrezPBerrySHaysRDPsychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test InvestigatorsArch Ophthalmol1998116149615049823352
PubMed Web of Science ®Google Scholar
FungAERosenfeldPJReichelEThe International Intravitreal Bevacizumab Safety Survey: using the Internet to assess drug safety worldwideBr J Ophthalmol2006901344134916854824
PubMed Web of Science ®Google Scholar
LalwaniGARosenfeldPJFungAEA variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO StudyAm J Ophthalmol20091484358.e119376495
PubMed Web of Science ®Google Scholar
MangioneCMLeePPGutierrezPRSpritzerKBerrySHaysRDDevelopment of the 25-item National Eye Institute Visual Function QuestionnaireArch Ophthalmol20011191050105811448327
PubMed Web of Science ®Google Scholar
SuzukamoYOshikaTYuzawaMPsychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese versionHealth Qual Life Outcomes200536516248900
PubMedGoogle Scholar
HymanLGKomaroffEHeijlABengtssonBLeskeMCTreatment and vision-related quality of life in the early manifest glaucoma trialOphthalmology20051121505151316019074
PubMed Web of Science ®Google Scholar
MaguireMBaseline characteristics, the 25-item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT)Ophthalmology20041111307131615234130
PubMed Web of Science ®Google Scholar
HirneissCNeubauerASGassCAVisual quality of life after macular hole surgery: outcome and predictive factorsBr J Ophthalmol20079148148417077117
PubMed Web of Science ®Google Scholar
CusickMSanGiovanniJPChewEYCentral visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetesAm J Ophthalmol20051391042105015953434
PubMed Web of Science ®Google Scholar
OkamotoFOkamotoYHiraokaTOshikaTVision-related quality of life and visual function after retinal detachment surgeryAm J Ophthalmol2008146859018400201
PubMed Web of Science ®Google Scholar
MarukoIIidaTSaitoMNagayamaDSaitoKClinical characteristics of exudative age-related macular degeneration in Japanese patientsAm J Ophthalmol2007144152217509509
PubMed Web of Science ®Google Scholar
BresslerNMChangTSFineJTDolanCMWardJImproved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trialArch Ophthalmol2009127132119139332
PubMed Web of Science ®Google Scholar
SunerIJKokameGTYuEWardJDolanCBresslerNMResponsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trialsInvest Ophthalmol Vis Sci2009503629363519255158
PubMed Web of Science ®Google Scholar
ToKGMeulenersLBFraserMLThe impact of cataract surgery on vision-related quality of life for bilateral cataract patients in Ho Chi Minh City, Vietnam: a prospective studyHealth Qual Life Outcomes2014121624499481
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date